ALK− ALCL is defined by the current WHO classification as a CD30+ PTCL lacking expression of the ALK protein, yet it is otherwise morphologically indistinguishable from ALK+ ALCL [9]. This evidence concerns the gene TNFRSF8 and anaplastic large cell lymphoma.